CEYLON GUARDIAN INVESTMENT TRUST PLC Financial Summary

GUAR.N0000 · CEYLON GUARDIAN INVESTMENT TRUST PLC · Financial Services · 2026-08-15

Ceylon Guardian Investment Trust PLC Financial Summary and Investment Analysis

Executive Overview

Ceylon Guardian Investment Trust PLC is the holding company of the Carson Cumberbatch Group’s investment business. It manages investments across listed equities, private equity, fixed income and overseas assets, while subsidiary Guardian Fund Management Limited provides portfolio-management services. At 2026-03-31, the Group managed a total investment portfolio of approximately Rs.41.42 Bn, including its strategic investment in Bukit Darah PLC.

Periods analysed: Q2 2024 through Q2 2026, plus the audited 12 months ended 2026-03-31.

The underlying financial position remains strong, but earnings are inherently volatile because changes in listed investment values flow through profit/loss or other comprehensive income. The 12 months ended 2026-03-31 produced Rs.4.09 Bn PAT, strong operating cash generation and a 21% expansion in equity, although investment returns lagged the exceptionally strong Colombo market. Q2 2026 remained profitable but was materially weaker YoY.

Financial Performance

Revenue and Profitability Trends

*Rs. million except EPS.*

PeriodRevenueFair-Value Gain/(Loss) through P&LInvestment Activity Profit/(Loss)PATEPS (Rs.)
Q2 2024535.6431.7967.2744.87.23
Q3 2024347.2(88.7)258.550.30.59
Q4 2024714.32,798.53,512.83,293.332.01
Q1 2025905.1(351.0)554.1322.03.15
Q2 2025521.11,887.82,408.92,176.421.48
Q3 2025845.21,176.72,021.91,726.117.29
Q4 20251,776.9(894.7)882.3609.76.01
Q1 2026730.6(875.5)(144.9)(422.4)(3.95)
Q2 2026538.4372.1910.6619.16.26

Gross profit/GP margin and EBITDA are not meaningful measures for this investment-holding model because there is no conventional cost-of-sales structure.

Q2 2026 revenue increased 3% YoY, but PAT declined 72%, mainly because P&L fair-value gains dropped 80% from Rs.1.89 Bn to Rs.372 Mn. Administrative expenses increased 15% and finance expense 78%. Sequentially, however, Q2 2026 represented a significant recovery from Q1 2026's Rs.422 Mn loss as fair-value movements returned positive.

For the 12 months ended 2026-03-31, revenue rose 55% to Rs.3.87 Bn, supported by Rs.1.75 Bn disposal gains and Rs.1.45 Bn interest income. PAT nevertheless declined 7% to Rs.4.09 Bn because fair-value gains through P&L fell 54%, finance costs increased sharply and tax expense rose 27%.

Balance Sheet Analysis

Group metric2025-03-312026-03-312026-06-30
Total assetsRs.35.36 BnRs.43.29 BnRs.43.78 Bn
Total equityRs.34.15 BnRs.41.37 BnRs.41.93 Bn
Parent equityRs.28.63 BnRs.34.81 BnRs.35.30 Bn
Cash & equivalentsRs.3.56 BnRs.10.11 BnRs.10.38 Bn
Interest-bearing debtRs.1.03 BnRs.1.74 BnRs.1.66 Bn
Current ratio41.05x35.96x35.70x
Debt/total equity~3.0%~4.2%~4.0%

Liquidity is exceptionally strong. At 2026-03-31, cash alone represented 24% of net assets, while the Group also had Rs.2.31 Bn of unutilised overdraft facilities. Leverage remains low despite increased borrowings.

Cash Flow Analysis

PeriodOperating CFInvesting CFFinancing CFNet Cash Change
12M to 2025-03-31Rs.2.38 Bn(Rs.20 Mn)(Rs.1.01 Bn)Rs.1.34 Bn
12M to 2026-03-31Rs.6.49 Bn(Rs.51 Mn)Rs.14 MnRs.6.45 Bn
Q2 2026Rs.272 Mn(Rs.0.5 Mn)(Rs.124 Mn)Rs.147 Mn

Operating cash generation increased 173% in the latest audited year, largely reflecting portfolio disposals and investment movements. Capital expenditure was only Rs.11.3 Mn, leaving substantial financial flexibility. Q2 2026 operating cash flow also improved markedly from the Rs.901 Mn outflow in Q2 2025.

Key Financial Ratios and Growth Indicators

Metric2025-03-312026-03-31
Return on ordinary shareholders' funds12.86%10.04%
EPSRs.42.41Rs.40.82
NAV/shareRs.334.24Rs.406.43
Market priceRs.153.25Rs.231.25
P/E3.61x5.67x
P/B0.46x0.57x
Dividend/shareRs.1.36Rs.5.50
Dividend payout3.21%13.47%

Based on Q2 2026 parent equity and issued ordinary/deferred shares, NAV was approximately Rs.412.10 per share. Against the 2026-06-30 market price of Rs.237.50, this represented an approximately 42% discount. The merged report's latest 2026-08-14 close of Rs.226.50 implies roughly a 45% discount to the stale June NAV, so subsequent portfolio movements remain important.

Portfolio Performance and Positioning

The total portfolio returned 22.52% dividend-adjusted during the 12 months ended 2026-03-31, while the active portfolio returned 20.17%. Both materially underperformed the 33.21% ASPI, although they exceeded fixed-deposit returns. Management was a substantial net seller, with Rs.7.41 Bn of equity sales versus Rs.1.15 Bn of purchases, crystallising gains and increasing liquidity.

Largest active positions at 2026-03-31 included Hemas Holdings PLC (Rs.1.61 Bn), Central Finance Company PLC (Rs.1.42 Bn), HNB Life PLC (Rs.960 Mn), Distilleries Company of Sri Lanka PLC and Sunshine Holdings PLC. The top ten represented 24.21% of active holdings. Overseas investments remained conservatively positioned toward short-duration U.S. Treasuries, high-quality corporate bonds and selected global equities.

Economic and Market Context

Management reported Sri Lankan GDP growth of 5.0% in 2025, reserves of approximately US$7.0 Bn by March 2026, fiscal revenue growth of 35% and a Rs.1.7 Tn primary surplus. Low inflation and interest rates supported equities, but risks increased from global tariffs, geopolitical conflict, energy-price pressures and domestic cyclone-related reconstruction requirements. Management expects higher energy costs and inflation to pressure corporate demand, margins and investor confidence.

Future Potential and Outlook

The strategy remains focused on fundamental equity selection, high-credit-quality fixed income and maintaining liquidity for market opportunities. The elevated cash position provides substantial capacity to redeploy capital if valuations become attractive.

A significant subsequent event was the 2026-07-23 repurchase offer of 1 share for every 53 shares held, at Rs.406.43 per share, covering up to 1,510,529 ordinary and 105,609 deferred shares for approximately Rs.657 Mn net of taxes.

Risks and Challenges

  • Market/fair-value risk: quarterly profits can swing by billions because investment price movements are recognised directly.
  • Benchmark underperformance: despite positive absolute returns, both total and active portfolios lagged the ASPI during the latest audited year.
  • Macroeconomic/geopolitical risk: energy prices, inflation, global trade disruption and domestic reform execution affect portfolio companies.
  • Interest-rate/currency risk: relevant to fixed-income and overseas holdings.
  • Concentration: strategic and major equity positions can materially affect NAV.
  • Share liquidity: average daily turnover over the latest 90 sessions was only about Rs.1.51 Mn, with median turnover around Rs.420,000.
  • Valuation dependence: investment valuation was the principal key audit matter; FVTPL and FVOCI investments represented approximately 55% of 2026-03-31 total assets.

The 2026-03-31 financial statements received an unmodified audit opinion. No material contingencies, litigation, capital commitments or going-concern uncertainties were reported.

Shareholder and Corporate Information

Carson Cumberbatch PLC controlled 68.26% at 2026-03-31; Employees Provident Fund held 3.58% and GF Capital Global Limited 2.12%. Public holding was 31.60%, increasing to 2,147 public shareholders by 2026-06-30. Directors reported no direct shareholdings at that date.

Investment Decision Indicators

Strengths

  • Large, diversified Rs.40+ Bn investment base.
  • Very low leverage and exceptional liquidity.
  • Strong audited operating cash generation.
  • NAV grew substantially while shares continue to trade at a large NAV discount.
  • Active capital recycling and conservative overseas positioning.
  • No material going-concern, litigation or contingency concerns.

Weaknesses / Threats

  • Earnings are highly dependent on equity-market fair-value movements.
  • Q2 2026 PAT fell 72% YoY.
  • Portfolio returns have recently lagged the ASPI.
  • ROE declined despite higher NAV.
  • Low trading liquidity can amplify share-price volatility.
  • A large NAV discount can persist indefinitely without a catalyst.

Overall assessment: the reports show a financially strong, highly liquid investment company with significant asset backing and a persistent market-price discount, but not a stable-earnings business. The central investment questions are whether future portfolio returns can outperform sufficiently, whether the NAV discount narrows, and whether capital actions such as repurchases meaningfully improve shareholder value. These factors should be weighed against substantial quarterly fair-value volatility and recent benchmark underperformance rather than interpreted as a BUY, SELL or HOLD recommendation.